Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Diabetes Mellitus, Type 2 × Sulfonylurea Compounds × 1 year × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Pulmonary Disease, Chronic Obstructive 1 Pancreatic Neoplasms 1 Lung Neoplasms 1 Disease 1 Diabetes Mellitus, Type 2 1

Interventions

relacorilant 3 saxagliptin 1 mazdutide 1 dapagliflozin 1 Urine Specimen Collection 1 Sulfonylurea Compounds 1 Sodium-Glucose Transporter 2 Inhibitors 1 Nutrition Assessment 1 Dipeptidyl-Peptidase IV Inhibitors 1 Blood Specimen Collection 1 Biopsy 1 ASP3662 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07332156 2026-01-14

Lung Cancer Risk in Type 2 Diabetes With COPD: SGLT2 Inhibitors vs. Sulfonylureas

Samsung Medical Center

21,692 enrolled

Diabetes Mellitus, Type 2, Disease, Lung Neoplasms, Pulmonary Disease, Chronic Obstructive

Data powered by HemOnc (CC BY 4.0) Colophon ⚡